76 related articles for article (PubMed ID: 12702897)
1. Valproic acid for the treatment of social anxiety disorder.
Kinrys G; Pollack MH; Simon NM; Worthington JJ; Nardi AE; Versiani M
Int Clin Psychopharmacol; 2003 May; 18(3):169-72. PubMed ID: 12702897
[TBL] [Abstract][Full Text] [Related]
2. Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder.
Adler LA; Liebowitz M; Kronenberger W; Qiao M; Rubin R; Hollandbeck M; Deldar A; Schuh K; Durell T
Depress Anxiety; 2009; 26(3):212-21. PubMed ID: 19194995
[TBL] [Abstract][Full Text] [Related]
3. Sodium valproate in the treatment of aggressive behavior in patients with dementia--a randomized placebo controlled clinical trial.
Sival RC; Haffmans PM; Jansen PA; Duursma SA; Eikelenboom P
Int J Geriatr Psychiatry; 2002 Jun; 17(6):579-85. PubMed ID: 12112183
[TBL] [Abstract][Full Text] [Related]
4. Double-blind comparison of 30 and 60 mg tranylcypromine daily in patients with panic disorder comorbid with social anxiety disorder.
Nardi AE; Lopes FL; Valença AM; Freire RC; Nascimento I; Veras AB; Mezzasalma MA; de-Melo-Neto VL; Soares-Filho GL; King AL; Grivet LO; Rassi A; Versiani M
Psychiatry Res; 2010 Feb; 175(3):260-5. PubMed ID: 20036427
[TBL] [Abstract][Full Text] [Related]
5. Social anxiety symptoms across diagnoses among outpatients attending a tertiary care mood and anxiety disorders service.
Graystone HJ; Garner MJ; Baldwin DS
J Affect Disord; 2009 Apr; 114(1-3):305-9. PubMed ID: 18656267
[TBL] [Abstract][Full Text] [Related]
6. Levetiracetam in social phobia: a placebo controlled pilot study.
Zhang W; Connor KM; Davidson JR
J Psychopharmacol; 2005 Sep; 19(5):551-3. PubMed ID: 16166192
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.
Rynn M; Russell J; Erickson J; Detke MJ; Ball S; Dinkel J; Rickels K; Raskin J
Depress Anxiety; 2008; 25(3):182-9. PubMed ID: 17311303
[TBL] [Abstract][Full Text] [Related]
9. Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: a flexible-dose, open-label pilot trial.
Katzman MA; Vermani M; Jacobs L; Marcus M; Kong B; Lessard S; Galarraga W; Struzik L; Gendron A
J Anxiety Disord; 2008 Dec; 22(8):1480-6. PubMed ID: 18455360
[TBL] [Abstract][Full Text] [Related]
10. Buspirone in social phobia.
Schneier FR; Saoud JB; Campeas R; Fallon BA; Hollander E; Coplan J; Liebowitz MR
J Clin Psychopharmacol; 1993 Aug; 13(4):251-6. PubMed ID: 8376612
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine.
Allgulander C; Mangano R; Zhang J; Dahl AA; Lepola U; Sjödin I; Emilien G;
Hum Psychopharmacol; 2004 Aug; 19(6):387-96. PubMed ID: 15303242
[TBL] [Abstract][Full Text] [Related]
12. Escitalopram in the treatment of social anxiety disorder: analysis of efficacy for different clinical subgroups and symptom dimensions.
Stein DJ; Kasper S; Andersen EW; Nil R; Lader M
Depress Anxiety; 2004; 20(4):175-81. PubMed ID: 15643634
[TBL] [Abstract][Full Text] [Related]
13. Moclobemide and cognitive behavioral therapy in the treatment of social phobia. A six-month controlled study and 24 months follow up.
Prasko J; Dockery C; Horácek J; Houbová P; Kosová J; Klaschka J; Pasková B; Praskova H; Seifertová D; Záleský R; Höschl C
Neuro Endocrinol Lett; 2006 Aug; 27(4):473-81. PubMed ID: 16891998
[TBL] [Abstract][Full Text] [Related]
14. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
16. Bupropion-SR in treatment of social phobia.
Emmanuel NP; Brawman-Mintzer O; Morton WA; Book SW; Johnson MR; Lorberbaum JP; Ballenger JC; Lydiard RB
Depress Anxiety; 2000; 12(2):111-3. PubMed ID: 11091936
[TBL] [Abstract][Full Text] [Related]
17. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.
Bose A; Korotzer A; Gommoll C; Li D
Depress Anxiety; 2008; 25(10):854-61. PubMed ID: 18050245
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy of generalized anxiety disorder: results of duloxetine treatment from a pooled analysis of three clinical trials.
Allgulander C; Hartford J; Russell J; Ball S; Erickson J; Raskin J; Rynn M
Curr Med Res Opin; 2007 Jun; 23(6):1245-52. PubMed ID: 17559726
[TBL] [Abstract][Full Text] [Related]
19. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
Alpert JE; Franznick DA; Hollander SB; Fava M
J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
[TBL] [Abstract][Full Text] [Related]
20. Divalproex in the treatment of bipolar depression: a placebo-controlled study.
Davis LL; Bartolucci A; Petty F
J Affect Disord; 2005 Apr; 85(3):259-66. PubMed ID: 15780695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]